Mi2 Antibodies
Santa Cruz Biotechnology supplies a comprehensive collection of Mi2 Antibodies for advanced research in molecular biology. Mi2 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Mi2 proteins are essential components in chromatin remodeling and gene regulation, influencing cellular processes such as differentiation and development. The role of Mi2 in modulating transcriptional activity makes it particularly relevant for understanding various diseases, including cancer and autoimmune disorders. Research focusing on Mi2 reveals important insights into gene expression mechanisms and potential therapeutic interventions. Mi2 monoclonal antibodies enable detailed investigation of chromatin structure modifications and their impact on cellular function. Understanding Mi2's role in gene regulation pathways opens new possibilities for therapeutic development. The extensive selection of Mi2 monoclonal antibodies from Santa Cruz Biotechnology empowers researchers worldwide to advance scientific understanding of gene regulation and disease mechanisms.
SEE ALSO...
Learn more about our ImmunoCruz® Antibody Conjugates and Cruz Marker™ MW Standards Promotional
Mi2 Antibodies
| Empty Table Header | Product Name | CATALOG # | ISOTYPE | EPITOPE | APPLICATIONS | Species | Citations | RATING |
|---|---|---|---|---|---|---|---|---|
Mi2 Antibody (B-4) | sc-55606 | mouse IgA | 1671-1912 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 6 | ||
Mi2-α Antibody (2172C1a) | sc-81323 | mouse IgG1 | C-Terminal (h) | WB, IP | h | new | ||
Mi2-β Antibody (F-7) | sc-365639 | mouse IgG3 κ | 1887-1909 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | new | ||
Mi2-β Antibody (H-7) | sc-393647 | mouse IgG3 κ | 100-121 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | new | ||
Mi2-β Antibody (F-3) | sc-365638 | mouse IgG1 κ | 1887-1909 (h) | WB, IP, IF, ELISA | m, r, h | 2 | ||
Mi2-β Antibody (H-8) | sc-373820 | mouse IgM κ | 1887-1909 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
Mi2-β Antibody (SW-88) | sc-134386 | mouse IgG2a κ | 1632-1731 (h) | WB, IP, IF, IHC(P), ELISA | h | new |
Mi2 CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Product Name | CATALOG # | Species | APPLICATIONS | MARKER | Citations | RATING |
|---|---|---|---|---|---|---|---|
Mi2-α CRISPR/Cas9 KO Plasmid (h) | sc-408715 | h | Gene Knockout | GFP | 0 | ||
Mi2-α HDR Plasmid (h) | sc-408715-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Mi2-α Double Nickase Plasmid (h) | sc-408715-NIC | h | Gene Knockout | Puromycin | 0 | ||
Mi2-α Double Nickase Plasmid (h2) | sc-408715-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Mi2-α CRISPR/Cas9 KO Plasmid (m) | sc-432131 | m | Gene Knockout | GFP | 0 | ||
Mi2-α HDR Plasmid (m) | sc-432131-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Mi2-α Double Nickase Plasmid (m) | sc-432131-NIC | m | Gene Knockout | Puromycin | 0 | ||
Mi2-α Double Nickase Plasmid (m2) | sc-432131-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Mi2-β CRISPR/Cas9 KO Plasmid (m) | sc-430771 | m | Gene Knockout | GFP | 0 | ||
Mi2-β HDR Plasmid (m) | sc-430771-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Mi2-β Double Nickase Plasmid (m) | sc-430771-NIC | m | Gene Knockout | Puromycin | 0 | ||
Mi2-β Double Nickase Plasmid (m2) | sc-430771-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Mi2-b CRISPR/Cas9 KO Plasmid (h) | sc-402185 | h | Gene Knockout | GFP | 0 | ||
Mi2-b HDR Plasmid (h) | sc-402185-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Mi2-b Double Nickase Plasmid (h) | sc-402185-NIC | h | Gene Knockout | Puromycin | 0 | ||
Mi2-b Double Nickase Plasmid (h2) | sc-402185-NIC-2 | h | Gene Knockout | Puromycin | 0 |
Mi2 CRISPR Activation Products
| Empty Table Header | Product Name | CATALOG # | Species | APPLICATIONS | MARKER | Citations | RATING |
|---|---|---|---|---|---|---|---|
Mi2-α CRISPR Activation Plasmid (h) | sc-408715-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Mi2-α CRISPR Activation Plasmid (h2) | sc-408715-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Mi2-α Lentiviral Activation Particles (h) | sc-408715-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Mi2-α Lentiviral Activation Particles (h2) | sc-408715-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Mi2-α CRISPR Activation Plasmid (m) | sc-432131-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Mi2-α CRISPR Activation Plasmid (m2) | sc-432131-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Mi2-α Lentiviral Activation Particles (m) | sc-432131-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Mi2-α Lentiviral Activation Particles (m2) | sc-432131-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Mi2-β CRISPR Activation Plasmid (m) | sc-430771-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Mi2-β CRISPR Activation Plasmid (m2) | sc-430771-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Mi2-β Lentiviral Activation Particles (m) | sc-430771-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Mi2-β Lentiviral Activation Particles (m2) | sc-430771-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Mi2-b CRISPR Activation Plasmid (h) | sc-402185-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Mi2-b CRISPR Activation Plasmid (h2) | sc-402185-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Mi2-b Lentiviral Activation Particles (h) | sc-402185-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Mi2-b Lentiviral Activation Particles (h2) | sc-402185-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 |
Mi2 siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Product Name | CATALOG # | Species | APPLICATIONS | MARKER | Citations | RATING |
|---|---|---|---|---|---|---|---|
Mi2-β siRNA (h) | sc-37953 | h | Gene Silencing | N/A | 1 | ||
Mi2-β shRNA Plasmid (h) | sc-37953-SH | h | Gene Silencing | Puromycin | 1 | ||
Mi2-β shRNA (h) Lentiviral Particles | sc-37953-V | h | Gene Silencing | Puromycin | 1 | ||
Mi2-β siRNA (m) | sc-37954 | m | Gene Silencing | N/A | 1 | ||
Mi2-β shRNA Plasmid (m) | sc-37954-SH | m | Gene Silencing | Puromycin | 1 | ||
Mi2-β shRNA (m) Lentiviral Particles | sc-37954-V | m | Gene Silencing | Puromycin | 1 | ||
Mi2α siRNA (h) | sc-37951 | h | Gene Silencing | N/A | 0 | ||
Mi2α shRNA Plasmid (h) | sc-37951-SH | h | Gene Silencing | Puromycin | 0 | ||
Mi2α shRNA (h) Lentiviral Particles | sc-37951-V | h | Gene Silencing | Puromycin | 0 | ||
Mi2α siRNA (m) | sc-37952 | m | Gene Silencing | N/A | 0 | ||
Mi2α shRNA Plasmid (m) | sc-37952-SH | m | Gene Silencing | Puromycin | 0 | ||
Mi2α shRNA (m) Lentiviral Particles | sc-37952-V | m | Gene Silencing | Puromycin | 0 |